Utilization of Host Polyamines in Alternatively Activated Macrophages Promotes Chronic Infection by Brucella abortus

• Published in: Infection and immunity 2018-03, Vol.86 (3)
• Main Authors: Kerrinnes, Tobias, Winter, Maria G, Young, Briana M, Diaz-Ochoa, Vladimir E, Winter, Sebastian E, Tsolis, Renée M
• Format: Article
• Language: English
• Subjects: Bacterial Infections; Spotlight
• ISSN: 0019-9567; 1098-5522
• DOI: 10.1128/IAI.00458-17

Treatment of intracellular bacterial pathogens with antibiotic therapy often requires a long course of multiple drugs. A barrier to developing strategies that enhance antibiotic efficacy against these pathogens is our poor understanding of the intracellular nutritional environment that maintains bacterial persistence. The intracellular pathogen survives and replicates preferentially in alternatively activated macrophages (AAMs); however, knowledge of the metabolic adaptations promoting exploitation of this niche is limited. Here we show that one mechanism promoting enhanced survival in AAMs is a shift in macrophage arginine utilization from production of nitric oxide (NO) to biosynthesis of polyamines, induced by interleukin 4 (IL-4)/IL-13 treatment. Production of polyamines by infected AAMs promoted both intracellular survival of and chronic infection in mice, as inhibition of macrophage polyamine synthesis or inactivation of the putative putrescine transporter encoded by reduced both intracellular survival in AAMs and persistence in mice. These results demonstrate that increased intracellular availability of polyamines induced by arginase-1 expression in IL-4/IL-13-induced AAMs promotes chronic persistence of within this niche and suggest that targeting of this pathway may aid in eradicating chronic infection.